Is MLMAD.PA stock a buy after the recent close at €11.70?

MLMAD.PA stock shows value metrics and a forecasted upside, but low liquidity raises execution risk. A volume-confirmed move above **€12.04** improves the case. This is analysis, not advice.

What price target does Meyka AI give for MLMAD.PA stock?

Meyka AI's model projects a **quarterly target €14.96** and a **yearly target €18.08** for MLMAD.PA stock. These are model projections and not guarantees.

What are the main risks for MLMAD.PA stock in an oversold-bounce trade?

Risk drivers are low daily volume (**150** today), small market cap **€14.99m**, and inventory levels. These increase volatility and the chance of a failed bounce.

How does MLMAD.PA stock compare to the Technology sector?

MLMAD.PA stock trades at a lower PE (~**13.45**) than the sector average (**31.12**), with stronger liquidity ratios but much smaller size and higher idiosyncratic risk.

EU Stocks

MLMAD.PA Made SA EURONEXT €11.70 closed 22 Jan 2026: oversold bounce, 54% upside

ByDanny Kontos January 23, 2026

We closed EURONEXT trading on 22 Jan 2026 with MLMAD.PA stock at €11.70, unchanged on the session and trading just above its 200-day average. Volume was light at 150 shares, which raises the chance of a short-term oversold bounce rather than a sustained trend change. We see a risk-reward setup: a confirmed recovery could target the model’s quarterly €14.96 and yearly €18.08 levels, while low liquidity keeps downside risk present.